SEARCH

SEARCH BY CITATION

References

  • 1
    Morrow JD, Chen Y, Brame CJ, Yang J, Sanchez SC, Xu J, et al. The isoprostanes: unique prostaglandin-like products of free-radical-initiated lipid peroxidation. Drug Metab Rev 1999;31:11739.
  • 2
    Wang W, Pang CC, Rogers MS, Chang AM. Lipid peroxidation in cord blood at birth. Am J Obstet Gynecol 1996;174:625.
  • 3
    Chu KO, Wang CC, Rogers MS, Pang CP. Quantifying F2-isoprostanes in umbilical cord blood of newborn by gas chromatography-mass spectrometry. Anal Biochem 2003;316:1117.
  • 4
    Kristal BS, Vigneau-Callahan KE, Moskowitz AJ, Matson WR. Purine catabolism: links to mitochondrial respiration and antioxidant defenses? Arch Biochem Biophys 1999;370:2233.
  • 5
    Pyska W, Klejewski A, Karolkiewicz J, Szczesniak L, Szczesniak-Chmielecka A, Nowak A. Imbalance of pro-oxidants-antioxidants in blood of pregnant women with pregnancy induced hypertension. Ginekol Pol 2002;73:148. (In Polish.)
  • 6
    Neves J, Cruz AS, Azevedo I, Vaz AC, Vasco P, Santos PJ, et al. Reduced and oxidized glutathione of the placenta in pregnancy complicated by pre-eclampsia. Acta Med Port 1997;10:35760. (In Portuguese.)
  • 7
    Zhang S, Yang W, Zhang M. Study on platelet antioxidant enzyme activity and platelet granule membrane glycoprotein in patients with pregnancy induced hypertension. Chung-Hua Fu Chan Ko Tsa Chih (Chinese J Obstet Gynecol) 1996;31:4614. (In Chinese.)
  • 8
    Uotila J, Tuimala R, Pyykko K, Ahotupa M. Pregnancy-induced hypertension is associated with changes in maternal and umbilical blood antioxidants. Gynecol Obstet Invest 1993;36:1537.
  • 9
    Many A, Hubel CA, Fisher SJ, Roberts JM, Zhou Y. Invasive cytotrophoblasts manifest evidence of oxidative stress in preeclampsia. Am J Pathol 2000;156:32131.
  • 10
    Roberts JM, Hubel CA. Is oxidative stress the link in the two-stage model of preeclampsia? Lancet 1999;354:7889.
  • 11
    Chappell LC, Seed PT, Briley A, Kelly FJ, Hunt BJ, Charnock-Jones DS, et al. A longitudinal study of biochemical variables in women at risk of preeclampsia. Am J Obstet Gynecol 2002;187:12736.
  • 12
    Parra M, Rodrigo R, Barja P, Bosco C, Fernandez V, Munoz H, et al. Screening test for preeclampsia through assessment of uteroplacental blood flow and biochemical markers of oxidative stress and endothelial dysfunction. Am J Obstet Gynecol 2005;193:148691.
  • 13
    Regan CL, Levine RJ, Baird DD, Ewell MG, Martz KL, Sibai BM, et al. No evidence for lipid peroxidation in severe preeclampsia. Am J Obstet Gynecol 2001;185:5728.
  • 14
    Ishihara O, Hayashi M, Osawa H, Kobayashi K, Takeda S, Vessby B, et al. Isoprostanes, prostaglandins and tocopherols in pre-eclampsia, normal pregnancy and non-pregnancy. Free Radic Res 2004;38:9138.
  • 15
    Hunt JV, Dean RT, Wolff SP. Hydroxyl radical production and autoxidative glycosylation. Glucose autoxidation as the cause of protein damage in the experimental glycation model of diabetes mellitus and ageing. J Biochem 1988;256:20512.
  • 16
    Paolisso G, D’Amore A, Volpe C, Balbi V, Saccomanno F, Galzerano D, et al. Evidence for a relationship between oxidative stress and insulin action in non-insulin dependant (type II) diabetic patients. Metabolism 1994;43:14269.
  • 17
    Evans JL, Goldfine ID, Maddux BA, Grodsky GM. Are oxidative stress activated signaling pathways mediators of insulin resistance and cell dysfunction? Diabetes 2003;52:18.
  • 18
    Skrha J, Hilgertova J. Relationship of N-acetyl-β-glucosaminidase activity to oxidative stress in diabetes mellitus. Clin Chim Acta 1999;282:16774.
  • 19
    Rogers MS, Arumanayagam M, Fung H, Lau TK. Diurnal variation in excretion of N-acetyl-beta-glucosaminidase during pregnancy: implications for the prediction of pre-eclampsia. Gynecol Obstet Invest 1999;47:912.
  • 20
    Roach VJ, Hin LY, Tam WH, Ng KB, Rogers MS. The incidence of pregnancy induced hypertension amongst patients with carbohydrate intolerance. Hypertens Pregnancy 2000;19:1839.
  • 21
    HAPO Study Cooperative Research Group. The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study. Int J Gynaecol Obstet 2002;78:6977.
  • 22
    Brown MA, Lindheimer MD, De Swiet M, Van Assche A, Moutquin JM. The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP) (Review). Hypertens Pregnancy 2001;20:IXXIV.
  • 23
    Rogers MS, Fung HY, Hung CY. Calcium and low-dose aspirin prophylaxis in women at high risk of pregnancy-induced hypertension. Hypertens Pregnancy 1999;18:16572.
  • 24
    Bradley AP and Longstaff ID. Sample size estimation using the receiver operating characteristic curve. ePrints, University of Queensland Library [www.eprint.uq.edu.au/archive/00003123/].